To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ASS1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
362 representative clones for gene ASS1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK027126 human small intestine .a 1 to 1946 1 to 1946 exact tiling clone, available from FLJ, AAA   1946/1946
(100 %)
0 diff
(100 %id)
NM_054012.3   .b 1 to 1785 1 to 1785 exact RefSeq, AAA   1785/1785
(100 %)
0 diff
(100 %id)
BF305325 muscle, rhabdomyosarcoma .b 166 to 733 1 to 567   tiling clone,   567/567
(100 %)
2 diff
(99.7 %id)
CB266823 adipose .b 174 to 661 1 to 487   tiling clone,   487/493
(98 %)
3 diff
(99.4 %id)
CX781331 human embryonic stem cells .b 194 to 932 1 to 739       739/739
(100 %)
0 diff
(100 %id)
DA615418   .b 206 to 770 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA704040   .b 222 to 685 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
DA004955   .b 224 to 675 2 to 453   capped   452/452
(100 %)
0 diff
(100 %id)
BC009243 Muscle, rhabdomyosarcoma .b 224 to 1785 1 to 1562   available from MGC, AAA   1562/1562
(100 %)
1 diff
(100.0 %id)
DA617951   .b 224 to 793 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA741431   .b 224 to 789 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB008262 cervix, tumor tissue .b 224 to 803 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DB190568 lung, tumor tissue .b 224 to 794 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BX422123 T cells (Jurkat cell line) .b 225 to 1264 1 to 1037       1037/1037
(100 %)
24 diff
(97.7 %id)
BE019397 muscle, rhabdomyosarcoma .b 225 to 863 1 to 640       640/678
(94 %)
3 diff
(99.6 %id)
BU179092 eye, retinoblastoma .b 225 to 895 1 to 672       672/840
(80 %)
4 diff
(99.6 %id)
CR598119 neuroblastoma .b 231 to 1740 1 to 1510       1510/1510
(100 %)
0 diff
(100 %id)
CR606338 neuroblastoma .b 232 to 1767 1 to 1536       1536/1536
(100 %)
0 diff
(100 %id)
BM837525 Ascites, stomach .b 236 to 859 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BG474110 eye, retinoblastoma .b 239 to 953 1 to 715       715/715
(100 %)
1 diff
(99.9 %id)
CD635509   .b 248 to 1049 803 to 1       803/803
(100 %)
5 diff
(99.4 %id)
CR625815 neuroblastoma .b 248 to 1763 1 to 1516       1516/1516
(100 %)
0 diff
(100 %id)
AK293114   .b 252 to 1779 1 to 1528       1528/1528
(100 %)
1 diff
(100.0 %id)
AK315093 Kidney .b 252 to 1533 1 to 1282       1282/1282
(100 %)
0 diff
(100 %id)
AU143006   .b 253 to 1047 2 to 800   capped   799/835
(95 %)
13 diff
(98.5 %id)
DA360391 subthalamic nucleus .b 254 to 796 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA367860 subthalamic nucleus .b 254 to 801 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
CU451422 epidermis .b 255 to 712 474 to 17     Submitted on the opposite strand 458/495
(92 %)
2 diff
(99.6 %id)
CU454279 epidermis .b 255 to 712 474 to 17     Submitted on the opposite strand 458/496
(92 %)
2 diff
(99.6 %id)
CU455808 epidermis .b 255 to 712 474 to 17     Submitted on the opposite strand 458/496
(92 %)
1 diff
(99.8 %id)
BM791358 stomach .b 255 to 880 1 to 626       626/626
(100 %)
0 diff
(100 %id)
BM791213 stomach .b 255 to 919 1 to 665       665/665
(100 %)
0 diff
(100 %id)
BC021676 Kidney .b 256 to 1760 5 to 1509   available from MGC, AAA   1505/1505
(100 %)
1 diff
(100.0 %id)
BM796289 stomach .b 256 to 820 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DA430837 colon .b 257 to 829 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AU143326   .b 257 to 1024 2 to 777   capped   774/826
(93 %)
9 diff
(99.0 %id)
BJ994378 hepatoblastoma .b 258 to 672 7 to 421       415/421
(98 %)
0 diff
(100 %id)
CR612736 B cells (Ramos cell line) Cot 25-normalized .b 260 to 1766 1 to 1507       1507/1507
(100 %)
0 diff
(100 %id)
CR616967 neuroblastoma .b 260 to 1724 1 to 1465       1465/1465
(100 %)
0 diff
(100 %id)
BX363984   .b 260 to 922 1 to 663   fully sequenced,   663/663
(100 %)
0 diff
(100 %id)
BG391009 embryonal carcinoma, cell line, testis .b 261 to 1026 1 to 762       760/800
(95 %)
15 diff
(98.2 %id)
BM747304 Ascites, stomach .b 261 to 834 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BM772608 Ascites, stomach .b 261 to 863 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BM773252 Ascites, stomach .b 261 to 706 1 to 446       446/446
(100 %)
0 diff
(100 %id)
CN482621 eye .b 263 to 880 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BE254827 eye, retinoblastoma .b 263 to 828 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BC013224.
matches multiple genes
cervical carcinoma cell line, cervix, Cervix, carcinoma .b 263 to 1785 1 to 1523   available from MGC, AAA also hits gene TOR3A 1523/1523
(100 %)
0 diff
(100 %id)
BX338939 Placenta Cot 25-normalized .b 264 to 1064 1 to 801       801/801
(100 %)
9 diff
(98.9 %id)
BC012763 Uterus, endometrium adenocarcinoma .b 264 to 1759 475 to 1970   tiling clone, AAA   1496/1941
(77 %)
6 diff
(99.7 %id)
BI757364 brain .b 265 to 1104 1 to 848       845/1116
(75 %)
17 diff
(98.5 %id)
CX759858 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 266 to 948 1 to 677     Submitted on the opposite strand 677/811
(83 %)
8 diff
(99.1 %id)
BE251389 eye, retinoblastoma .b 267 to 887 1 to 620       620/621
(99 %)
2 diff
(99.7 %id)
BE018019 cervical carcinoma cell line, cervix .b 270 to 803 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BI258439 cervical carcinoma cell line, cervix .b 270 to 1068 1 to 800       800/894
(89 %)
16 diff
(98.3 %id)
BI254017 cervical carcinoma cell line, cervix .b 270 to 1133 1 to 873       873/901
(96 %)
17 diff
(98.2 %id)
BI333295 cervical carcinoma cell line, cervix .b 270 to 945 1 to 676       676/676
(100 %)
0 diff
(100 %id)
BM552180 astrocytoma grade IV, cell line, brain .b 270 to 1140 1 to 872       872/1029
(84 %)
18 diff
(98.3 %id)
BU947830 insulinoma, Pancreas .b 270 to 862 1 to 593       593/593
(100 %)
6 diff
(99.0 %id)
DR004162 Liver .b 270 to 966 7 to 703       697/703
(99 %)
6 diff
(99.2 %id)
BI256461 cervical carcinoma cell line, cervix .b 271 to 1147 1 to 878       876/878
(99 %)
9 diff
(99.0 %id)
BI254203 cervical carcinoma cell line, cervix .b 271 to 1138 1 to 880       880/890
(98 %)
33 diff
(96.3 %id)
BI488612 brain .b 271 to 1235 1 to 956       956/978
(97 %)
31 diff
(96.9 %id)
BU167493 eye, retinoblastoma .b 271 to 1065 1 to 803       803/913
(87 %)
23 diff
(97.5 %id)
BQ926213 large cell carcinoma, lung .b 271 to 1068 1 to 805       805/930
(86 %)
19 diff
(98.0 %id)
BU158601 large cell carcinoma, lung .b 272 to 1062 1 to 798       798/890
(89 %)
17 diff
(98.1 %id)
BQ229554 large cell carcinoma, lung .b 272 to 1124 1 to 859       859/859
(100 %)
10 diff
(98.9 %id)
BX416453 neuroblastoma .b 274 to 1098 4 to 827   fully sequenced,   824/827
(99 %)
11 diff
(98.7 %id)
BI333825 cervical carcinoma cell line, cervix .b 274 to 944 1 to 672       670/672
(99 %)
0 diff
(100 %id)
BU181082 large cell carcinoma, lung .b 274 to 1129 1 to 862       862/887
(97 %)
15 diff
(98.4 %id)
BU175592 large cell carcinoma, lung .b 274 to 1118 1 to 857       853/865
(98 %)
16 diff
(98.2 %id)
BU194440 adenocarcinoma, Pancreas .b 274 to 1058 1 to 795       793/880
(90 %)
14 diff
(98.5 %id)
BQ933063 large cell carcinoma, lung .b 274 to 1064 1 to 792       792/941
(84 %)
11 diff
(98.9 %id)
BI256793 cervical carcinoma cell line, cervix .b 275 to 910 13 to 648       636/648
(98 %)
0 diff
(100 %id)
BI334615 cervical carcinoma cell line, cervix .b 275 to 845 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BI257913 cervical carcinoma cell line, cervix .b 276 to 1134 1 to 860       860/875
(98 %)
12 diff
(98.7 %id)
BQ900491 eye, retinoblastoma .b 276 to 1162 1 to 891       891/892
(99 %)
15 diff
(98.4 %id)
CD558975 White Matter .b 276 to 1024 1 to 757       757/877
(86 %)
10 diff
(98.9 %id)
BU539552 adenocarcinoma, cell line, breast .b 277 to 1139 1 to 873       873/889
(98 %)
16 diff
(98.3 %id)
BU539553 adenocarcinoma, cell line, breast .b 277 to 1068 1 to 797       797/909
(87 %)
10 diff
(98.9 %id)
BU187543 eye, retinoblastoma .b 278 to 1183 1 to 906       904/906
(99 %)
9 diff
(99.1 %id)
BU500199   .b 279 to 1131 12 to 872       861/938
(91 %)
12 diff
(98.8 %id)
BX425477 neuroblastoma .b 280 to 1162 32 to 914   fully sequenced,   883/914
(96 %)
3 diff
(99.7 %id)
BQ691464 ductal carcinoma, cell line, Pancreas .b 280 to 982 1 to 704       702/904
(77 %)
3 diff
(99.7 %id)
CN346807 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 281 to 777 3 to 499       497/499
(99 %)
0 diff
(100 %id)
BU500723   .b 281 to 1190 12 to 924       913/924
(98 %)
14 diff
(98.5 %id)
BE780945 eye, retinoblastoma .b 283 to 962 1 to 676       676/678
(99 %)
8 diff
(98.9 %id)
CD607242   .b 285 to 1014 1 to 729       729/729
(100 %)
6 diff
(99.2 %id)
CR592094 B cells (Ramos cell line) Cot 25-normalized .b 285 to 1713 1 to 1429       1429/1429
(100 %)
0 diff
(100 %id)
CR598476 placenta .b 285 to 1777 1 to 1493       1493/1493
(100 %)
0 diff
(100 %id)
CR601739 Placenta Cot 25-normalized .b 285 to 1749 1 to 1465       1465/1465
(100 %)
0 diff
(100 %id)
CR605717 HeLa cells Cot 25-normalized .b 285 to 1735 1 to 1451       1451/1451
(100 %)
0 diff
(100 %id)
CR606149 T cells (Jurkat cell line) .b 285 to 1771 1 to 1487       1487/1487
(100 %)
0 diff
(100 %id)
CR616527 Placenta Cot 25-normalized .b 285 to 1737 1 to 1453       1453/1453
(100 %)
0 diff
(100 %id)
CR620347 Placenta Cot 25-normalized .b 285 to 1750 1 to 1466       1466/1466
(100 %)
0 diff
(100 %id)
BX416027 neuroblastoma .b 285 to 1266 1 to 983       983/983
(100 %)
7 diff
(99.3 %id)
BX417933 placenta .b 285 to 1115 1 to 830   fully sequenced,   830/830
(100 %)
4 diff
(99.6 %id)
BX426491 T cells (Jurkat cell line) .b 285 to 1098 1 to 813   fully sequenced,   813/813
(100 %)
1 diff
(99.9 %id)
BX334582 Placenta Cot 25-normalized .b 285 to 922 1 to 638   fully sequenced,   638/638
(100 %)
0 diff
(100 %id)
BX334787 Placenta Cot 25-normalized .b 285 to 1098 1 to 814   fully sequenced,   814/814
(100 %)
0 diff
(100 %id)
BX337937 Placenta Cot 25-normalized .b 285 to 1098 1 to 816   fully sequenced,   816/816
(100 %)
2 diff
(99.8 %id)
BX359556 Placenta Cot 25-normalized .b 285 to 1013 1 to 728   fully sequenced,   728/728
(100 %)
0 diff
(100 %id)
BX362585   .b 285 to 1163 1 to 879   fully sequenced,   879/879
(100 %)
2 diff
(99.8 %id)
BX343008   .b 285 to 1167 1 to 886   fully sequenced,   886/886
(100 %)
9 diff
(99.0 %id)
BE264908 lung, small cell carcinoma .b 285 to 887 1 to 604       604/675
(89 %)
3 diff
(99.6 %id)
BM479666 embryonal carcinoma, cell line, testis .b 285 to 1269 21 to 1023       1003/1086
(92 %)
46 diff
(95.8 %id)
BM906426 ovary (pool of 3) .b 285 to 1197 24 to 942       919/1086
(84 %)
26 diff
(97.7 %id)
BU190420 large cell carcinoma, lung .b 285 to 1063 22 to 809       788/948
(83 %)
24 diff
(97.5 %id)
BU500337   .b 285 to 1188 25 to 929       905/929
(97 %)
10 diff
(99.0 %id)
BU500450   .b 285 to 1068 22 to 808       787/942
(83 %)
10 diff
(99.0 %id)
BE783168 eye, retinoblastoma .b 286 to 1068 1 to 787       787/1100
(71 %)
22 diff
(98.0 %id)
BM450792 eye, retinoblastoma .b 287 to 1134 1 to 849       849/1056
(80 %)
14 diff
(98.7 %id)
TI_1948077635   .b 288 to 1391 129 to 1251       1123/1388
(80 %)
70 diff
(95.0 %id)
BQ923639 epidermoid carcinoma, cell line, lung .b 290 to 1129 1 to 846       846/886
(95 %)
10 diff
(98.9 %id)
BE737349 adenocarcinoma, Pancreas .b 292 to 875 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BE294173 muscle, rhabdomyosarcoma .b 294 to 842 1 to 549       549/549
(100 %)
0 diff
(100 %id)
CR591395 Placenta Cot 25-normalized .b 295 to 1738 1 to 1444       1444/1444
(100 %)
0 diff
(100 %id)
CR615955 Placenta Cot 25-normalized .b 295 to 1723 1 to 1429       1429/1429
(100 %)
0 diff
(100 %id)
BX378551 Placenta Cot 25-normalized .b 295 to 1013 1 to 718   fully sequenced,   718/718
(100 %)
0 diff
(100 %id)
BX360160 Placenta Cot 25-normalized .b 295 to 922 1 to 628   fully sequenced,   628/628
(100 %)
0 diff
(100 %id)
CV027690 mixed .b 295 to 889 1 to 595       595/611
(97 %)
1 diff
(99.9 %id)
CV028798 mixed .b 295 to 791 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BE543638 cervical carcinoma cell line, cervix .b 296 to 1061 1 to 762       762/766
(99 %)
9 diff
(98.9 %id)
BG392449 embryonal carcinoma, cell line, testis .b 297 to 982 1 to 683       683/683
(100 %)
3 diff
(99.6 %id)
BI260468 cervical carcinoma cell line, cervix .b 297 to 1107 1 to 815       813/815
(99 %)
7 diff
(99.2 %id)
BI258628 cervical carcinoma cell line, cervix .b 297 to 1134 1 to 834       832/851
(97 %)
15 diff
(98.3 %id)
BI256559 cervical carcinoma cell line, cervix .b 297 to 1134 1 to 835       835/838
(99 %)
7 diff
(99.2 %id)
BI758987 pooled colon, kidney, stomach .b 297 to 1205 1 to 909       909/909
(100 %)
5 diff
(99.5 %id)
BM909765 astrocytoma grade IV, cell line, brain .b 298 to 1118 1 to 831       831/1107
(75 %)
16 diff
(98.6 %id)
BM466370 eye, retinoblastoma .b 298 to 1133 1 to 846       844/1015
(83 %)
18 diff
(98.3 %id)
BU173952 adenocarcinoma, Pancreas .b 298 to 1068 1 to 772       772/949
(81 %)
5 diff
(99.5 %id)
BQ889380 brain, neuroblastoma, cell line .b 298 to 1218 1 to 919       919/921
(99 %)
10 diff
(99.0 %id)
BQ890636 brain, neuroblastoma, cell line .b 298 to 1068 1 to 775       775/928
(83 %)
12 diff
(98.8 %id)
BM907354 large cell carcinoma, lung .b 299 to 1134 1 to 840       840/980
(85 %)
8 diff
(99.2 %id)
BU158798 embryonal carcinoma, cell line, testis .b 299 to 1178 1 to 886       886/894
(99 %)
17 diff
(98.1 %id)
BU164863 eye, retinoblastoma .b 299 to 1239 1 to 940       940/940
(100 %)
15 diff
(98.5 %id)
BU173072 eye, retinoblastoma .b 299 to 1063 1 to 768       768/900
(85 %)
7 diff
(99.3 %id)
BQ720111 sympathetic trunk .b 299 to 1068 1 to 774       774/929
(83 %)
8 diff
(99.2 %id)
BI258834 cervical carcinoma cell line, cervix .b 302 to 1134 1 to 831       831/878
(94 %)
8 diff
(99.1 %id)
BM903974 eye, retinoblastoma .b 302 to 1247 1 to 960       958/971
(98 %)
26 diff
(97.4 %id)
CN346805 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 309 to 565 1 to 257       257/257
(100 %)
0 diff
(100 %id)
CD607255   .b 316 to 1060 745 to 1       745/745
(100 %)
4 diff
(99.5 %id)
CD607243   .b 319 to 1050 731 to 1       731/731
(100 %)
1 diff
(99.9 %id)
CB154297 Liver .b 326 to 887 1 to 562       562/562
(100 %)
0 diff
(100 %id)
CB155924 Liver .b 376 to 975 1 to 600       600/600
(100 %)
0 diff
(100 %id)
TI_1948078278   .b 467 to 1532 1192 to 127       1064/1299
(81 %)
30 diff
(97.7 %id)
TI_1948078608   .b 467 to 1532 1183 to 127       1057/1279
(82 %)
36 diff
(97.2 %id)
TI_1948077636   .b 468 to 1532 1198 to 124       1071/1305
(82 %)
48 diff
(96.4 %id)
BE378581 endometrium, adenocarcinoma cell line, uterus .b 561 to 1380 1 to 814       814/952
(85 %)
7 diff
(99.3 %id)
AV647848 corresponding non cancerous liver tissue .b 592 to 977 1 to 386     Submitted on the opposite strand 386/386
(100 %)
0 diff
(100 %id)
Z36810 Pancreas .b 603 to 852 1 to 250       250/250
(100 %)
1 diff
(99.6 %id)
CD607252   .b 638 to 1060 423 to 1       423/423
(100 %)
0 diff
(100 %id)
CB161999 Liver .b 642 to 1199 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DB060949 testis .b 719 to 1254 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
CB157614 Liver .b 750 to 1309 1 to 560       560/560
(100 %)
0 diff
(100 %id)
G43543   .b 763 to 891 127 to 1     Submitted on the opposite strand 127/127
(100 %)
3 diff
(97.7 %id)
AA486050   .b 764 to 1261 8 to 505   fully sequenced,   498/505
(98 %)
0 diff
(100 %id)
BE745841 adenocarcinoma cell line, ovary .b 830 to 1560 1 to 730       730/731
(99 %)
2 diff
(99.8 %id)
BU169978 large cell carcinoma, lung .b 857 to 1740 1 to 892       892/892
(100 %)
20 diff
(97.8 %id)
AA128188 colon, tumor .b 859 to 943 1 to 85       85/85
(100 %)
0 diff
(100 %id)
BX334581 Placenta Cot 25-normalized .b 862 to 1749 887 to 1   fully sequenced,   887/887
(100 %)
6 diff
(99.4 %id)
BX339001 Placenta Cot 25-normalized .b 862 to 1711 860 to 12   fully sequenced,   849/860
(98 %)
1 diff
(99.9 %id)
BX363983   .b 862 to 1725 898 to 37   fully sequenced, AAA   862/879
(98 %)
0 diff
(100 %id)
CN346804 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 869 to 1056 1 to 188       188/188
(100 %)
0 diff
(100 %id)
AA402239 ovarian tumor, ovary .b 871 to 1376 1 to 506   fully sequenced,   506/506
(100 %)
0 diff
(100 %id)
BG674351 skin .b 913 to 1758 1 to 851       851/935
(91 %)
13 diff
(98.7 %id)
TI_154062111   .b 921 to 1779 949 to 102   AAA   850/975
(87 %)
16 diff
(98.4 %id)
TI_149276536   .b 935 to 1766 918 to 91   AAA   830/828
(100 %)
10 diff
(98.8 %id)
BE880239 large cell carcinoma, undifferentiated, lung .b 950 to 1628 1 to 677       677/677
(100 %)
3 diff
(99.6 %id)
BX378550 Placenta Cot 25-normalized .b 952 to 1738 785 to 1   fully sequenced,   785/785
(100 %)
3 diff
(99.7 %id)
BX359555 Placenta Cot 25-normalized .b 952 to 1725 779 to 9   fully sequenced,   771/779
(98 %)
2 diff
(99.8 %id)
BI223537 cervical carcinoma cell line, cervix .b 960 to 1716 1 to 760       760/760
(100 %)
5 diff
(99.4 %id)
BI260936 cervical carcinoma cell line, cervix .b 972 to 1682 24 to 735       712/735
(96 %)
3 diff
(99.6 %id)
BX416452 neuroblastoma .b 1037 to 1725 689 to 1   fully sequenced,   689/689
(100 %)
5 diff
(99.3 %id)
BX426490 T cells (Jurkat cell line) .b 1037 to 1771 737 to 1   fully sequenced,   737/737
(100 %)
6 diff
(99.2 %id)
BX334786 Placenta Cot 25-normalized .b 1037 to 1750 710 to 1   fully sequenced,   710/710
(100 %)
6 diff
(99.2 %id)
BX337936 Placenta Cot 25-normalized .b 1037 to 1737 700 to 1   fully sequenced,   700/700
(100 %)
3 diff
(99.6 %id)
BX454628 placenta .b 1085 to 1764 688 to 12   fully sequenced,   677/688
(98 %)
4 diff
(99.5 %id)
BX362584   .b 1102 to 1735 634 to 1   fully sequenced,   634/634
(100 %)
17 diff
(97.4 %id)
BX454070 neuroblastoma .b 1108 to 1776 664 to 1   fully sequenced,   664/664
(100 %)
9 diff
(98.7 %id)
BX352620   .b 1137 to 1713 576 to 1   fully sequenced,   576/576
(100 %)
6 diff
(99.0 %id)
AA488667   .b 1231 to 1765 536 to 2   fully sequenced,   535/536
(99 %)
0 diff
(100 %id)
BJ994379 hepatoblastoma .b 1233 to 1749 517 to 1       517/517
(100 %)
0 diff
(100 %id)
BE301439 cervical carcinoma cell line, cervix .b 1251 to 1779 542 to 14   AAA   529/529
(100 %)
2 diff
(99.7 %id)
AV655824 corresponding non cancerous liver tissue .b 1265 to 1764 1 to 500   AAA Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AA179226   .b 1275 to 1760 485 to 1     Submitted on the opposite strand 485/487
(99 %)
3 diff
(99.4 %id)
AA430025   .b 1276 to 1761 486 to 1       486/486
(100 %)
0 diff
(100 %id)
AA593873 colon, colon tumor .b 1276 to 1766 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AA486304   .b 1277 to 1747 471 to 1     Submitted on the opposite strand 471/471
(100 %)
3 diff
(99.4 %id)
AW802373 uterus .b 1281 to 1576 296 to 1       296/296
(100 %)
0 diff
(100 %id)
BG315170   .b 1283 to 1559 277 to 1       277/277
(100 %)
2 diff
(99.3 %id)
AA804703 liposarcoma .b 1288 to 1766 486 to 13   AAA   474/478
(99 %)
10 diff
(98.0 %id)
AI074371 colon, colon tumor .b 1289 to 1786 498 to 1       498/498
(100 %)
0 diff
(100 %id)
BE205921 muscle, rhabdomyosarcoma .b 1296 to 1786 498 to 8       491/498
(98 %)
0 diff
(100 %id)
AW001456 colon, colonic mucosa from 3 patients with Crohn'sdisease .b 1298 to 1766 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AI459387 brain, meningioma .b 1304 to 1750 447 to 1       447/447
(100 %)
0 diff
(100 %id)
AA194865   .b 1305 to 1760 458 to 1     Submitted on the opposite strand 458/458
(100 %)
2 diff
(99.6 %id)
AA847289 colon, colon tumor .b 1308 to 1779 490 to 19   AAA   472/472
(100 %)
1 diff
(99.8 %id)
BE927891 colon .b 1314 to 1700 388 to 1       388/388
(100 %)
4 diff
(99.0 %id)
AA188878   .b 1315 to 1765 450 to 1     Submitted on the opposite strand 450/451
(99 %)
4 diff
(99.2 %id)
BF806383 colon_ins .b 1317 to 1565 254 to 5     Submitted on the opposite strand 250/254
(98 %)
0 diff
(100 %id)
CV338950 breast .b 1322 to 1607 290 to 1     Submitted on the opposite strand 290/290
(100 %)
24 diff
(91.8 %id)
AI921791 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 1325 to 1765 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AA402700 ovarian tumor, ovary .b 1346 to 1785 451 to 12   fully sequenced, AAA   440/440
(100 %)
0 diff
(100 %id)
CA426978 Bone, Subchondral Bone .b 1356 to 1766 429 to 19   AAA   411/411
(100 %)
0 diff
(100 %id)
AI362548 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1360 to 1780 421 to 1       421/421
(100 %)
0 diff
(100 %id)
CN349443 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1361 to 1757 1 to 397       397/397
(100 %)
0 diff
(100 %id)
AI076715 liver and spleen .b 1362 to 1785 444 to 21   AAA   424/424
(100 %)
0 diff
(100 %id)
BE122840 skin .b 1370 to 1541 1 to 172       172/172
(100 %)
0 diff
(100 %id)
BC129942 PCR rescued clones .b 1370 to 1729 364 to 5     Submitted on the opposite strand 360/375
(96 %)
0 diff
(100 %id)
AA190498   .b 1371 to 1761 395 to 1     Submitted on the opposite strand 395/396
(99 %)
7 diff
(98.3 %id)
AA113087   .b 1372 to 1759 389 to 1     Submitted on the opposite strand 387/389
(99 %)
3 diff
(99.3 %id)
BQ220274 embryonal carcinoma, cell line, testis .b 1390 to 1764 1 to 375   AAA   375/375
(100 %)
0 diff
(100 %id)
CR608372 Neuroblastoma Cot 50-normalized .b 1421 to 1780 1 to 360       360/360
(100 %)
0 diff
(100 %id)
AW068315 Bone, Hip .b 1428 to 1748 321 to 1       321/321
(100 %)
0 diff
(100 %id)
AW004845 colon .b 1461 to 1766 306 to 1       306/306
(100 %)
0 diff
(100 %id)
AA180269   .b 1465 to 1785 335 to 13   AAA Submitted on the opposite strand 323/323
(100 %)
4 diff
(98.8 %id)
BG315480   .b 1470 to 1554 85 to 1       85/85
(100 %)
2 diff
(97.7 %id)
AA512973 normal prostate, Prostate .b 1474 to 1764 291 to 1       291/291
(100 %)
0 diff
(100 %id)
H56301 liver and spleen .b 1485 to 1649 165 to 1       165/165
(100 %)
0 diff
(100 %id)
BM725419 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1511 to 1766 1 to 256   AAA   256/256
(100 %)
0 diff
(100 %id)
BE673155 Prostate .b 1518 to 1766 249 to 1       249/249
(100 %)
0 diff
(100 %id)
AI459870 colon .b 1546 to 1755 210 to 1       210/210
(100 %)
0 diff
(100 %id)
AI659249 Prostate .b 1580 to 1766 187 to 1       187/187
(100 %)
0 diff
(100 %id)
R92705 liver and spleen .b 1650 to 1760 111 to 1       111/111
(100 %)
0 diff
(100 %id)
AA128189 colon, tumor .b 1661 to 1767 108 to 2       107/108
(99 %)
0 diff
(100 %id)
TI_45215829   .c 1 to 805 83 to 885       803/886
(90 %)
17 diff
(98.1 %id)
BI603075 brain, hypothalamus .c 6 to 805 1 to 799   tiling clone,   799/800
(99 %)
14 diff
(98.3 %id)
DB496935 hypothalamus .c 19 to 481 1 to 463       463/463
(100 %)
2 diff
(99.6 %id)
NM_000050.4   .c 19 to 1865 1 to 1847 exact RefSeq, AAA   1847/1847
(100 %)
0 diff
(100 %id)
DA253773 caudate nucleus .c 246 to 830 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BU158873 large cell carcinoma, lung .c 259 to 1072 1 to 815       815/873
(93 %)
8 diff
(99.1 %id)
TI_57197422   .c 259 to 1111 68 to 922       855/923
(92 %)
14 diff
(98.5 %id)
BI820747 pooled brain, lung, testis .c 261 to 1111 1 to 855       855/856
(99 %)
13 diff
(98.5 %id)
CR607007 HeLa cells Cot 25-normalized .c 268 to 1817 1 to 1550   tiling clone,   1550/1550
(100 %)
0 diff
(100 %id)
DA035073 breast .c 275 to 757 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
AL702683 human skeletal muscle .c 275 to 565 1 to 291       291/291
(100 %)
3 diff
(99.0 %id)
DA614484   .c 275 to 842 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AU143277   .c 275 to 980 2 to 707   capped   706/715
(98 %)
7 diff
(99.1 %id)
BG898145 cartilage .c 281 to 569 79 to 367       289/299
(96 %)
6 diff
(98.0 %id)
BX401254   .c 287 to 1002 21 to 736   fully sequenced,   716/736
(97 %)
6 diff
(99.2 %id)
BI114589 muscle, rhabdomyosarcoma .c 287 to 705 1 to 424       424/808
(52 %)
11 diff
(98.7 %id)
BF725480 eye, Iris .c 293 to 831 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BX433413 adult brain, brain .c 296 to 1016 724 to 1       724/894
(80 %)
18 diff
(98.0 %id)
X01630   .c 300 to 1839 1 to 1540   AAA   1540/1540
(100 %)
4 diff
(99.8 %id)
CD607251   .c 303 to 1023 1 to 722       722/722
(100 %)
1 diff
(99.9 %id)
BX446754 neuroblastoma .c 307 to 1147 1 to 841       841/841
(100 %)
2 diff
(99.8 %id)
CD607250   .c 331 to 1140 809 to 1       809/809
(100 %)
2 diff
(99.8 %id)
CR604563 neuroblastoma .c 366 to 1811 1 to 1446       1446/1446
(100 %)
0 diff
(100 %id)
BC052288 Muscle, rhabdomyosarcoma .c 367 to 1847 1 to 1481   tiling clone, available from MGC, AAA   1481/2372
(62 %)
2 diff
(100.0 %id)
BX401253   .c 942 to 1797 882 to 20   fully sequenced,   863/882
(97 %)
15 diff
(98.3 %id)
CR595936 adult brain .d 1 to 1895 1 to 1895 exact tiling clone,   1895/1895
(100 %)
0 diff
(100 %id)
BX422936 adult brain, brain .d 1 to 945 1 to 947       947/953
(99 %)
6 diff
(99.4 %id)
CR605897 neuroblastoma .e 1 to 1518 1 to 1518 exact tiling clone,   1518/1518
(100 %)
0 diff
(100 %id)
BX438082 neuroblastoma .e 1 to 854 1 to 854   fully sequenced,   854/854
(100 %)
1 diff
(99.9 %id)
TI_59390204   .e 86 to 885 107 to 904     Suspected internal deletion 796/851
(93 %)
33 diff
(96.2 %id)
BX438081 neuroblastoma .e 793 to 1489 725 to 29   fully sequenced,   697/725
(96 %)
2 diff
(99.8 %id)
CR619067 neuroblastoma .f 1 to 1530 1 to 1530 exact tiling clone,   1530/1530
(100 %)
0 diff
(100 %id)
CR597457 neuroblastoma .f 26 to 1479 1 to 1454       1454/1454
(100 %)
0 diff
(100 %id)
DC360937   .g 1 to 455 1 to 456   tiling clone,   456/456
(100 %)
2 diff
(99.6 %id)
AA315248 colon .g 230 to 463 1 to 234   tiling clone,   234/234
(100 %)
0 diff
(100 %id)
DC426172   .g 1163 to 1715 553 to 1   tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
BQ719604 sympathetic trunk .h 1 to 805 24 to 831   tiling clone,   815/962
(84 %)
13 diff
(98.7 %id)
DA703084   .h 111 to 599 2 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
BQ943387 brain, neuroblastoma, cell line .h 439 to 1356 1 to 924   tiling clone,   924/924
(100 %)
11 diff
(98.9 %id)
BU500363   .h 442 to 1359 22 to 944       923/946
(97 %)
20 diff
(97.9 %id)
BI253130 cervical carcinoma cell line, cervix .h 514 to 1404 1 to 894       895/900
(99 %)
25 diff
(97.3 %id)
BG181074 adenocarcinoma, cell line, Prostate .h 659 to 1407 1 to 751   tiling clone, AAA   749/902
(83 %)
22 diff
(97.6 %id)
BE546795 cervical carcinoma cell line, cervix .h 700 to 1405 1 to 702   tiling clone,   702/768
(91 %)
9 diff
(98.9 %id)
BE540910 cervix .h 702 to 1405 9 to 712       704/811
(86 %)
18 diff
(97.8 %id)
BE563856 adenocarcinoma, Pancreas .h 766 to 1400 1 to 643       643/967
(66 %)
29 diff
(97.1 %id)
T71317 Liver .h 882 to 1402 1 to 525     Submitted on the opposite strand 525/538
(97 %)
16 diff
(97.1 %id)
AA186363   .h 882 to 1409 1 to 524   tiling clone, Submitted on the opposite strand 526/569
(92 %)
12 diff
(97.9 %id)
AA196286   .h 928 to 1409 1 to 481   tiling clone, Submitted on the opposite strand 481/560
(85 %)
15 diff
(97.4 %id)
CR609148 T cells (Jurkat cell line) Cot10-normalized .i 1 to 1359 6 to 1364 exact tiling clone,   1364/1364
(100 %)
0 diff
(100 %id)
BI113695 muscle, rhabdomyosarcoma .j 1 to 835 1 to 836 exact tiling clone,   836/852
(98 %)
19 diff
(97.8 %id)
BI113930 muscle, rhabdomyosarcoma .j 1 to 727 1 to 735 A194D     735/790
(93 %)
19 diff
(97.6 %id)
BF309119 muscle, rhabdomyosarcoma .j 7 to 588 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BI113984 muscle, rhabdomyosarcoma .j 9 to 470 1 to 462       462/465
(99 %)
1 diff
(99.8 %id)
BF205642 muscle, rhabdomyosarcoma .j 20 to 666 1 to 655       655/765
(85 %)
18 diff
(97.7 %id)
BI114933 muscle, rhabdomyosarcoma .j 22 to 825 1 to 794       794/804
(98 %)
33 diff
(95.9 %id)
BF310042 muscle, rhabdomyosarcoma .j 25 to 358 1 to 331       331/331
(100 %)
5 diff
(98.5 %id)
BG825163 muscle, rhabdomyosarcoma .j 34 to 732 1 to 701       701/701
(100 %)
3 diff
(99.6 %id)
TI_149284091   .j 38 to 821 852 to 82   AAA   771/807
(95 %)
17 diff
(97.9 %id)
TI_149299427   .j 38 to 834 882 to 90   AAA   793/968
(81 %)
6 diff
(99.4 %id)
BF306940 muscle, rhabdomyosarcoma .j 45 to 841 1 to 801       801/910
(88 %)
26 diff
(97.2 %id)
BF203395 muscle, rhabdomyosarcoma .j 51 to 800 1 to 754       754/1082
(69 %)
15 diff
(98.7 %id)
BF306409 muscle, rhabdomyosarcoma .j 51 to 667 1 to 616       616/617
(99 %)
5 diff
(99.2 %id)
AA132630 colon, tumor .j 55 to 495 1 to 439   fully sequenced,   439/439
(100 %)
2 diff
(99.6 %id)
AW001394 colon, colonic mucosa from 3 patients with Crohn'sdisease .j 67 to 822 755 to 1       755/755
(100 %)
11 diff
(98.6 %id)
BF793185 adrenal cortex carcinoma, cell line, adrenal gland .j 72 to 816 1 to 743       743/756
(98 %)
8 diff
(99.0 %id)
BF303930 muscle, rhabdomyosarcoma .j 75 to 785 1 to 715       715/1187
(60 %)
27 diff
(97.8 %id)
BM850485 stomach .j 81 to 579 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
CR613193 Neuroblastoma Cot 50-normalized .j 84 to 822 1 to 739       739/739
(100 %)
0 diff
(100 %id)
AL529364 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .j 84 to 822 1 to 740       740/740
(100 %)
11 diff
(98.6 %id)
AI660571 colon, colonic mucosa from 3 patients with Crohn'sdisease .j 85 to 822 740 to 2       739/740
(99 %)
10 diff
(98.7 %id)
BE394983 endometrium, adenocarcinoma cell line, uterus .j 96 to 760 1 to 657       657/687
(95 %)
14 diff
(98.0 %id)
BX411929 neuroblastoma .j 100 to 830 728 to 1       728/907
(80 %)
7 diff
(99.3 %id)
AI191444 lung .j 100 to 834 765 to 15   AAA   751/751
(100 %)
18 diff
(97.7 %id)
BM795271 stomach .j 110 to 695 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
CB850758 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 111 to 834 742 to 19   AAA   724/724
(100 %)
1 diff
(99.9 %id)
BU632573 cell lines, Chondrosarcoma .j 111 to 814 722 to 19   AAA   704/704
(100 %)
1 diff
(99.9 %id)
CA421020 Bone, Enchondroma cell line .j 117 to 834 736 to 19   AAA   718/718
(100 %)
0 diff
(100 %id)
BM798695 stomach .j 118 to 653 1 to 536       536/536
(100 %)
5 diff
(99.1 %id)
BQ183612 Knee, Osteoarthritic Cartilage .j 123 to 821 715 to 17   AAA   699/705
(99 %)
1 diff
(99.9 %id)
CA428300 Bone, Subchondral Bone .j 123 to 834 730 to 19   AAA   712/723
(98 %)
1 diff
(99.9 %id)
BU624608 cell lines, Enchondroma .j 123 to 834 728 to 19   AAA   712/712
(100 %)
3 diff
(99.6 %id)
TI_154125052   .j 124 to 840 802 to 91   AAA   710/937
(75 %)
9 diff
(99.1 %id)
BM984441 lung, Primary Lung Epithelial Cells .j 127 to 821 705 to 17   AAA   689/689
(100 %)
7 diff
(99.0 %id)
BU677241 lung, Primary Lung Epithelial Cells .j 128 to 821 709 to 17   AAA   695/693
(100 %)
2 diff
(99.8 %id)
CA440371 lung, Lung Focal Fibrosis .j 128 to 821 712 to 19   AAA   694/694
(100 %)
1 diff
(99.9 %id)
TI_149312651   .j 148 to 821 758 to 85   AAA   674/968
(69 %)
2 diff
(99.8 %id)
BM978116 lung .j 148 to 821 690 to 17   AAA   674/686
(98 %)
2 diff
(99.8 %id)
BM562928 astrocytoma grade IV, cell line, brain .j 152 to 835 29 to 713   AAA   685/1127
(60 %)
12 diff
(99.0 %id)
CA427043 Bone, Subchondral Bone .j 156 to 834 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
BG928437 cartilage .j 161 to 631 87 to 556       470/487
(96 %)
6 diff
(98.8 %id)
BF305206 muscle, rhabdomyosarcoma .j 164 to 876 1 to 717   tiling clone,   717/823
(87 %)
11 diff
(98.7 %id)
BU621776 cell lines, Chondrosarcoma .j 167 to 819 671 to 19   AAA   653/653
(100 %)
1 diff
(99.9 %id)
AW007170 anaplastic oligodendroglioma, brain .j 169 to 822 654 to 1       654/654
(100 %)
14 diff
(97.9 %id)
BU628702 Bone, Enchondroma cell line .j 174 to 834 679 to 19   AAA   661/661
(100 %)
0 diff
(100 %id)
BU153327 large cell carcinoma, lung .j 176 to 821 1 to 646   AAA   646/646
(100 %)
2 diff
(99.7 %id)
BQ324376 colon_ins .j 177 to 636 9 to 468       460/472
(97 %)
2 diff
(99.6 %id)
BQ303537 breast .j 178 to 593 4 to 420       417/420
(99 %)
13 diff
(97.0 %id)
TI_149295674   .j 178 to 821 750 to 107   AAA   644/910
(70 %)
5 diff
(99.5 %id)
AW027921 brain, glioblastoma (pooled) .j 181 to 834 652 to 1       652/655
(99 %)
17 diff
(97.5 %id)
TI_158432725   .j 187 to 821 723 to 87   AAA   637/995
(64 %)
4 diff
(99.6 %id)
AW057755 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j 188 to 834 656 to 11   AAA   646/655
(98 %)
11 diff
(98.4 %id)
BM856425 stomach .j 192 to 765 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
BE049643 adenocarcinoma, Pancreas .j 193 to 822 633 to 3       631/633
(99 %)
2 diff
(99.7 %id)
CA416011 Chondrosarcoma Cell line .j 194 to 840 663 to 19   AAA   645/645
(100 %)
2 diff
(99.7 %id)
AI677997 adenocarcinoma, Pancreas .j 195 to 814 628 to 11   AAA   618/618
(100 %)
11 diff
(98.3 %id)
BQ647534 hepatocellular carcinoma, cell line, Liver .j 195 to 834 1 to 640   AAA   640/640
(100 %)
1 diff
(99.9 %id)
AW300638 colon, moderately differentiated adenocarcinoma .j 196 to 814 617 to 1       617/617
(100 %)
4 diff
(99.4 %id)
BF111916 pooled .j 196 to 835 642 to 3       640/642
(99 %)
2 diff
(99.7 %id)
AI434575 lymph node, lymphoma, follicular mixed small and largecell .j 200 to 822 616 to 2       615/616
(99 %)
16 diff
(97.5 %id)
BQ376981 uterus .j 202 to 601 15 to 414       400/414
(96 %)
6 diff
(98.6 %id)
BQ376986 uterus .j 202 to 586 15 to 398       384/398
(96 %)
5 diff
(98.8 %id)
AW081475 colon, moderately differentiated adenocarcinoma .j 202 to 820 621 to 5       617/621
(99 %)
4 diff
(99.4 %id)
BG058344 dorsal root ganglia .j 202 to 841 642 to 3   tiling clone,   640/642
(99 %)
19 diff
(97.1 %id)
AA421202   .j 203 to 524 1 to 321   fully sequenced,   321/321
(100 %)
1 diff
(99.7 %id)
BU789821 insulinoma, Pancreas .j 226 to 507 7 to 288   fully sequenced,   282/288
(97 %)
1 diff
(99.7 %id)
BM819795 stomach .j 231 to 619 1 to 389       389/389
(100 %)
2 diff
(99.5 %id)
BE393272 endometrium, adenocarcinoma cell line, uterus .j 235 to 819 1 to 586       586/586
(100 %)
3 diff
(99.5 %id)
TI_57200571   .j 235 to 825 70 to 661   AAA   592/661
(89 %)
9 diff
(98.7 %id)
BI821421 pooled brain, lung, testis .j 238 to 825 1 to 589   AAA   589/589
(100 %)
3 diff
(99.5 %id)
BE383012 brain, neuroblastoma .j 241 to 825 139 to 720   AAA   582/720
(80 %)
18 diff
(97.5 %id)
CF528603 placenta .j 253 to 821 584 to 16   AAA   569/569
(100 %)
0 diff
(100 %id)
AA488187 whole brain .j 254 to 817 562 to 1       562/562
(100 %)
6 diff
(99.0 %id)
T51288 fetal spleen, Spleen .j 257 to 809 564 to 12       553/564
(98 %)
6 diff
(99.0 %id)
AW615604 lung, small cell carcinoma .j 259 to 822 562 to 2       561/562
(99 %)
11 diff
(98.1 %id)
BQ376991 uterus .j 260 to 642 394 to 12       383/394
(97 %)
0 diff
(100 %id)
AW409854.
matches multiple genes
muscle, rhabdomyosarcoma .j 262 to 819 576 to 19   AAA also hits gene RPL22andCHD5 558/558
(100 %)
1 diff
(99.9 %id)
BU683811 lung, Primary Lung Cystic Fibrosis EpithelialCells .j 265 to 821 568 to 12   AAA   557/557
(100 %)
0 diff
(100 %id)
AW409835.
matches multiple genes
muscle, rhabdomyosarcoma .j 270 to 819 576 to 27     also hits gene TEF 550/576
(95 %)
0 diff
(100 %id)
AW409856.
matches multiple genes
muscle, rhabdomyosarcoma .j 270 to 819 572 to 23   AAA also hits gene RPRD1A 550/550
(100 %)
2 diff
(99.7 %id)
AW409878 muscle, rhabdomyosarcoma .j 270 to 819 576 to 27   AAA   550/550
(100 %)
0 diff
(100 %id)
AA188216   .j 271 to 811 538 to 1     Submitted on the opposite strand 538/538
(100 %)
5 diff
(99.1 %id)
AA486496   .j 272 to 835 566 to 3     Submitted on the opposite strand 564/566
(99 %)
1 diff
(99.9 %id)
AI126733 heart .j 272 to 822 549 to 2       548/551
(99 %)
13 diff
(97.7 %id)
AW591499 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 274 to 821 547 to 1       547/547
(100 %)
11 diff
(98.0 %id)
BF197120 pooled .j 274 to 822 554 to 6       549/554
(99 %)
0 diff
(100 %id)
W03180 liver and spleen .j 275 to 781 1 to 513       513/514
(99 %)
14 diff
(97.3 %id)
BQ324011 colon_ins .j 279 to 643 375 to 12       364/375
(97 %)
0 diff
(100 %id)
AW674203   .j 286 to 820 541 to 9       533/541
(98 %)
3 diff
(99.5 %id)
AI469676 colon, moderately-differentiated adenocarcinoma .j 288 to 821 530 to 1       530/530
(100 %)
8 diff
(98.5 %id)
AW410178.
matches multiple genes
muscle, rhabdomyosarcoma .j 288 to 814 598 to 72   AAA Submitted on the opposite strand, also hits gene C11orf24 527/527
(100 %)
0 diff
(100 %id)
AI016575   .j 289 to 822 535 to 5       531/535
(99 %)
8 diff
(98.6 %id)
AI687559 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .j 289 to 821 561 to 31   AAA   531/531
(100 %)
13 diff
(97.6 %id)
CA488055   .j 293 to 840 1 to 548   AAA   548/548
(100 %)
0 diff
(100 %id)
AA847234 colon, colon tumor .j 301 to 792 491 to 1       491/491
(100 %)
3 diff
(99.4 %id)
AI355319 lung .j 308 to 819 512 to 1       512/512
(100 %)
0 diff
(100 %id)
AA132447 colon, tumor .j 446 to 732 288 to 1   fully sequenced,   288/288
(100 %)
1 diff
(99.7 %id)
BU789549 insulinoma, Pancreas .j 446 to 822 378 to 2   fully sequenced,   377/378
(99 %)
0 diff
(100 %id)
AA416583   .j 494 to 817 324 to 1   fully sequenced,   324/324
(100 %)
0 diff
(100 %id)
BF307513 muscle, rhabdomyosarcoma .k 1 to 628 1 to 628 P9R tiling clone,   628/628
(100 %)
2 diff
(99.7 %id)
BG826159 muscle, rhabdomyosarcoma .k 1 to 705 1 to 712 A116D D159* tiling clone,   712/775
(91 %)
20 diff
(97.5 %id)
BG827739 muscle, rhabdomyosarcoma .l 1 to 783 1 to 790 E12A V13G C15L R16* tiling clone,   790/948
(83 %)
35 diff
(96.4 %id)
BF308863 muscle, rhabdomyosarcoma .l 2 to 729 1 to 726   tiling clone,   726/930
(78 %)
15 diff
(98.4 %id)
BE297462 muscle, rhabdomyosarcoma .l 4 to 703 30 to 726   tiling clone,   697/734
(94 %)
8 diff
(99.0 %id)
W15177 lung .m 1 to 549 1 to 537   tiling clone, fully sequenced,   539/539
(100 %)
13 diff
(97.6 %id)
N78671 lung .m 534 to 981 450 to 1   tiling clone, fully sequenced,   450/450
(100 %)
8 diff
(98.3 %id)
BQ898559 dorsal root ganglia .n-u 1 to 792 1 to 800 H52P A99G R100A P102S P103A ... tiling clone,   800/873
(91 %)
16 diff
(98.2 %id)
BE543731 cervical carcinoma cell line, cervix .o 1 to 710 1 to 722 G96A K97E V98S Q99G V100T ... tiling clone,   719/778
(92 %)
15 diff
(98.1 %id)
DA171074 amygdala .p-u 1 to 537 2 to 537 exact tiling clone, capped   536/536
(100 %)
1 diff
(99.9 %id)
AI056778 liver and spleen .q-u 1 to 383 383 to 1 exact tiling clone,   383/383
(100 %)
0 diff
(100 %id)
AI078194 liver and spleen .q-u 11 to 383 373 to 1 exact     373/373
(100 %)
0 diff
(100 %id)
AI140567 liver and spleen .q-u 35 to 389 355 to 1 V35G tiling clone,   355/355
(100 %)
2 diff
(99.5 %id)
S73202   .r 1 to 91 1 to 91 P7L tiling clone,   91/91
(100 %)
4 diff
(95.7 %id)
AK304625 uterus Gene ASS1, variant not shown         Suspected internal deletion, this clone was ignored    
335 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n-u, .o, .p-u, .q-u, .r Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI